A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients

References

• SinghD, AgustiA, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, SeemungalTAR, PatelIS, Lloyd-OwenSJ, WilkinsonTMA, WedzichaJA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003;22(6):931–936. doi:10.1183/09031936.03.0003830314680081
   PubMed Web of Science ®Google Scholar
• CazzolaM, MacNeeW, MartinezFJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416–469. doi:10.1183/09031936.0009930618238951
   PubMed Web of Science ®Google Scholar
• SullivanSD, StrasselsSA, SmithDH. Characterization of the costs of chronic obstructive pulmonary disease (COPD) in the US. Eur Respir J. 2016;9(suppl23):412S.
   Google Scholar
• HartlS, Lopez-CamposJL, Pozo-RodriguezF, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2015;47(1):113–121.26493806
   PubMed Web of Science ®Google Scholar
• SuissaS, Dell’AnielloS, ErnstP. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963.22684094
   PubMed Web of Science ®Google Scholar
• HalpinDMG, DecramerM, CelliBR, MuellerA, MetzdorfN, TashkinDP. Effect of a single exacerbation on decline in lung function in COPD. Respir Med. 2017;128:85–91.28610675
   PubMed Web of Science ®Google Scholar
• DransfieldMT, KunisakiKM, StrandMJ, et al. Acute exacerbations and lung function loss in smokers with and without COPD. Am J Respir Crit Care Med. 2017;195(3):324–330.27556408
   PubMed Web of Science ®Google Scholar
• CelliBR, ThomasNE, AndersonJA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(4):332–338.18511702
   PubMed Web of Science ®Google Scholar
• WANGQ, BOURBEAUJ. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology. 2005;10(3):334–340. doi:10.1111/res.2005.10.issue-315955146
   PubMed Web of Science ®Google Scholar
• AnderssonI, JohanssonK, LarssonS, PehrssonK. Long-term oxygen therapy and quality of life in elderly patients hospitalised due to severe exacerbation of COPD. A 1 year follow-up study. Respir Med. 2002;96(11):944–949. doi:10.1053/rmed.2002.137012418593
   PubMed Web of Science ®Google Scholar
• SpencerS, JonesPW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003;58(7):589–593. doi:10.1136/thorax.58.7.58912832673
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• HanMK, QuibreraPM, CarrettaEE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-228668356
   PubMed Web of Science ®Google Scholar
• BertensLC, ReitsmaJB, MoonsKG, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:493–499. doi:10.2147/COPD.S4960924143086
   PubMed Web of Science ®Google Scholar
• PuhanMA, Garcia-AymerichJ, FreyM, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. LANCET. 2009;374(9691):704–711. doi:10.1016/S0140-6736(09)61301-519716962
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med. 2004;350(10):05–12. doi:10.1056/NEJMoa021322
   Web of Science ®Google Scholar
• JonesRC, DonaldsonGC, ChavannesNH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(12):1189–1195. doi:10.1164/rccm.200902-0271OC19797160
   PubMed Web of Science ®Google Scholar
• NiewoehnerDE, LokhnyginaY, RiceK, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131(1):20–28. doi:10.1378/chest.06-131617218552
   PubMed Web of Science ®Google Scholar
• GuerraB, GaveikaiteV, BianchiC, PuhanMA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):160061. doi:10.1183/16000617.0061-201628096287
   PubMed Web of Science ®Google Scholar
• CouperD, LaVangeLM, HanM, et al. Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS): table 1. Thorax. 2014;69(5):492–495. doi:10.1136/thoraxjnl-2013-203897
   Web of Science ®Google Scholar
• GadouryM. Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J. 2005;26(5):853–857. doi:10.1183/09031936.05.0009320416264046
   PubMed Web of Science ®Google Scholar
• PouwEM, VeldeGPM, CroonenBHPM, et al. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. 2000;19(2):95–99. doi:10.1054/clnu.1999.007410867726
   PubMed Web of Science ®Google Scholar
• MüllerovaH, MaselliDJ, LocantoreN, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007. doi:10.1378/chest.14-065525356881
   PubMed Web of Science ®Google Scholar
• MitsikiE, AlexopoulosE, GourgoulianisK, BaniaE, VarounisC, MalliF. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study). Int J Chronic Obstruct Pulmon Dis. 2015;10:2665–2674. doi:10.2147/COPD.S91392
   PubMed Web of Science ®Google Scholar
• BensonVS, MüllerováH, VestboJ, WedzichaJA, PatelA, HurstJR. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med. 2015;109(9):1147–1154. doi:10.1016/j.rmed.2015.06.00926166017
   PubMed Web of Science ®Google Scholar
• TzanakisN, HillasG, PerlikosF, TsiligianniI. Managing comorbidities in COPD. Int J Chronic Obstruct Pulmon Dis.. 2015;10:95–109. doi:10.2147/COPD.S54473
   PubMed Web of Science ®Google Scholar
• BarnesN, CalverleyPM, KaplanA, RabeKF. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global hidden depths of COPD survey. BMC Pulm Med. 2013;13:54. doi:10.1186/1471-2466-13-5423971625
   PubMed Web of Science ®Google Scholar
• JoYS, YoonHI, KimDK, YooC, LeeC. Comparison of COPD assessment test and clinical COPD questionnaire to predict the risk of exacerbation. Int J Chronic Obstructive Pulm Dis. 2018;13:101–107.
   PubMed Web of Science ®Google Scholar
• Montserrat-CapdevilaJ, GodoyP, MarsalJR, BarbéF, GalvánL. Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study. Int J Tuberculosis Lung Dis. 2016;20(3):389–395. doi:10.5588/ijtld.15.0441
   PubMed Web of Science ®Google Scholar
• DivoM, CoteC, de TorresJP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161.22561964
   PubMed Web of Science ®Google Scholar
• FreiA, MuggensturmP, PutchaN, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904–911. doi:10.1016/j.jclinepi.2014.03.00524786594
   PubMed Web of Science ®Google Scholar
• YiiAC, LohCH, TiewPY, et al. A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”. Int J Chron Obstruct Pulmon Dis. 2019;14:719–728.30988606
   PubMed Web of Science ®Google Scholar
• GotoT, CamargoCA, FaridiMK, YunBJ, HasegawaK. Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED. Am J Emerg Med. 2018;36(9):1650–1654.29970272
   PubMed Web of Science ®Google Scholar
• RennardS, DecramerM, CalverleyPMA, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of confronting COPD international survey. Eur Respir J. 2002;20(4):799–805.12412667
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.20843247
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJ, Serra PonsI, ManninoDM, MaasAK, MillerDP, DavisKJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66(7):585–590.21515553
   PubMed Web of Science ®Google Scholar
• GARCIA-AYMERICHJ, MONSOE, MARRADESRM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164(6):1002–1007.11587986
   PubMed Web of Science ®Google Scholar
• MiravitllesM, GuerreroT, MayordomoC, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration. 2000;67(5):495–501.11070451
   PubMed Web of Science ®Google Scholar
• ErikssonB, LindbergA, MüllerovaH, RönmarkE, LundbäckB. Association of heart diseases with COPD and restrictive lung function – results from a population survey. Respir Med. 2013;107(1):98–106.23127573
   PubMed Web of Science ®Google Scholar
• GhobadiH, AhariSS, KameliA, LariSM. The relationship between COPD Assessment Test (CAT) scores and severity of airflow obstruction in stable COPD patients. Tanaffos. 2012;11(2):22–26.25191410
   PubMedGoogle Scholar
• LariSM, GhobadiH, AttaranD, MahmoodpourA, ShadkamO, RostamiM. COPD assessment test (CAT): simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease. Clin Respir J. 2014;8(1):116–123.23910892
   PubMed Web of Science ®Google Scholar
• JonesPW, BrusselleG, Dal NegroRW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.21565915
   PubMed Web of Science ®Google Scholar
• LeeS, HuangM, KangJ, et al. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108(4):600–608.24456695
   PubMed Web of Science ®Google Scholar
• BarnesPJ, CelliBR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185.19407051
   PubMed Web of Science ®Google Scholar
• LariS, AttaranD, TohidiM. Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD assessment test in primary care. Patient Relat Outcome Meas. 2014;5:145–152.25422591
   PubMedGoogle Scholar
• MoonsKG, RoystonP, VergouweY, et al. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.19237405
   PubMed Web of Science ®Google Scholar